论文部分内容阅读
美国遗传技术公司与卢布里佐尔公司和菲泽公司达成一项协议,利用遗传饰变细菌生产抗坏血酸即维生素C。生产工艺只有两步,而如今大部分抗坏血酸是采用传统的赖克斯坦一格鲁斯纳六步法生产的。这项工艺的商业化标志着首次采用遗传工程技术生产工业量的化学品。目前用作维
U.S. Genetics Technologies and Lubrizol and Fizi reached an agreement to use genetically altered bacteria to produce vitamin C, which is ascorbic acid. There are only two steps in the production process, and today most of the ascorbic acid is produced using the traditional six-step method of Reistein-Grusner. The commercialization of this process marks the first time that genetic engineering technology has been used to produce industrial quantities of chemicals. Currently used as a dimension